Sumalinog, Juryl B.
HRN: 22-08-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2022
METRONIDAZOLE 500MG (TAB)
11/21/2022
11/26/2022
PO
500mg
Q8 X 5 Days
S/P LTCS
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes